YMAB   $10.41  3.07% Market Closed After Close 10.41 0.0

Y-mAbs Therapeutics Inc
Total Cash 77.81M
totalCashPerShare 1.746
EBITDA -27.00M
Total Debt 1.27M
quickRatio 2.3
currentRatio 2.916
Total Revenue 86.55M
debtToEquity 1.336
Revenue/Share 1.978
ROA -0.12501
ROE -0.24611
grossProfits
freeCashflow -5.68M
operatingCashflow -12.55M
earningsGrowth
revenueGrowth 0.099
grossMargins 0.88625
ebitdaMargins -0.31202
operatingMargins -0.42938
profitMargins -0.28439
enterpriseValue 596.47M
forwardPE -29.055553
floatShares 27.07M
sharesOutstanding 44.57M
sharesShort 4.25M
sharesShortPriorMonth 4.03M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.70%
Short Ratio help_outline 17.35%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 2.139
Price To Book help_outline 7.34
earningsQuarterlyGrowth
netIncomeToCommon -24.61M
trailingEps -0.56%
forwardEps -0.54%
enterpriseToEbitda -22.09
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 3Q 2024
institutionsCount 161
lastUpdated Nov. 7, 2024, 2:54 a.m.